Alliancebernstein L.P. Oramed Pharmaceuticals Inc. Transaction History

Alliancebernstein L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$3.72 - $9.0 $62,124 - $150,300	-16,700 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$12.98 - $29.75 $86,966 - $199,325	6,700 Added 67.0%	16,700 $238,000
Q2 2021 Jul 30, 2021	BUY	$8.34 - $14.59 $83,400 - $145,900	10,000 New	10,000 $134,000

7.4M

2.1K

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $90.9M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.